IOF World Congress on Osteoporosis

Back to Homepage

Satellite Symposia
(updated 26.4.2002)

Friday, May 10, 2002
15:15 – 17:00 (Auditorium 1)

Optimizing Bone Formation and Resorption with Strontium Ranelate:
An Innovative Therapeutic Approach to Osteoporosis

Sponsor: Servier

Co-chairs: P.D. Delmas and J.D. Ringe


Reduced bone formation: A rational target for the treatment of osteoporosis
E. Seeman

The calcium-sensing receptor as a molecular target for the biological actions of strontium ranelate
E. M. Brown

Optimizing bone metabolism in osteoporosis: Insight into the pharmacological profile of strontium ranelate
P.J. Marie

Dose-related bone effects of strontium ranelate in postmenopausal women
P.J. Meunier and J.Y. Reginster

Strontium ranelate anti-fracture study program: Current data
J.Y. Reginster and P.J. Meunier